AG
URGN icon

Algert Global’s UroGen Pharma URGN Stock Holding History

Algert Global’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$341K Sell
18,990
-46,945
-71% -$941K 0.01% 1011
2025
Q4 		$1.54M Buy
+65,935
New +$1.43M 0.02% 770
2022
Q3 		– Sell
-10,350
Closed -$85K – 1350
2022
Q2 		$85K Sell
10,350
-190
-2% -$1.3K 0.01% 1131
2022
Q1 		$92K Buy
+10,540
New +$82.2K 0.01% 1110
2021
Q2 		– Sell
-11,630
Closed -$227K – 532
2021
Q1 		$227K Buy
+11,630
New +$247K 0.07% 359
2020
Q3 		– Sell
-10,880
Closed -$284K – 488
2020
Q2 		$284K Buy
+10,880
New +$266K 0.1% 279

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return